MRI Lawsuits: Gadolinium Contrast Agents
Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy could be caused by gadolinium for those with kidney problems. >>REQUEST A FREE CLAIM REVIEW
The lawyers at Saiontz, Kirk & Miles, P.A. are investigating MRI lawsuits for those with kidney problems who have been diagnosed with Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NFD), after receiving an MRI or MRA with contrast.
Gadolinium based injections used as a contrast agent could cause those with impaired kidney function to develop the serious and potentially fatal disorder, which is associated with the formation of thick and hard skin on the arms and legs, as well as the fibrosis of organs.
>>OBTAIN AN MRI LAWSUIT CONSULTATION<<
Potential lawsuits are being reviewed nationwide for any individuals who have experienced symptoms of the MRI skin problems, which could nclude:
- Burning, itching, swellinng, hardening and tightening of the skin
- Red or dark patches on the skin
- Yellow spots on the whites of the eyes
- Stiff joints with trouble straightening or moving the limbs
- Pain in the hip bones or ribs
- Generalized muscle weakness
GADOLINIUM MRI CONTRAST PROBLEMS FOR THOSE WITH KIDNEY DISEASE
There are five Gadolinium contrast agents which have been approved by the FDA:
- Omniscan (gadodiamide)
- MultiHance (gadobenate dimeglumine)
- Magnevist (gadopentetate dimeglumine)
- ProHance (gadoteridol)
- OptiMARK (gadoversetamide)
In 1997 the first cases of Nephrogenic Fibrosing Dermopathy (NFD), were identified, when individuals with impaired kidney function developed areas of thick and hard skin which severely restricted their movement. The condition was later renamed Nephrogenic Systemic Fibrosis (NSF) as additional information was gathered and it was determined that fibrosis, or scarring, can form on other internal organs throughout the system.
In 2006, researchers found that there is a direct connection between development of this rare disorder and the use of gadolinium contrast agents during magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) for those with kidney problems. The manufacturers failed to properly research their products or warn of the potential risk the contrasts pose for individuals with kidney problems. As a result, MRI lawsuits are being reviewed throughout the United States by the lawyers at Saiontz, Kirk & Miles, P.A.
NEPHROGENIC SYSTEMIC FIBROSIS LAWSUITS
NFS/NFD is a progressive disorder which is associated with the development of excessive scar tissue and thick, hardened and tight areas of skin which often cover the joints, resulting in severe limitations on movement. In many cases it renders the victim unable to walk or fully move the joints of their arms, hands, legs and/or feet, and they become dependent on a wheelchair within weeks of the onset. There is no known cure or effective treatment for Nephrogenic Systemic Fibrosis, and in some cases it can lead to death.
>>INFORMATION: Symptoms of NSF/NFD
MRI GADOLINIUM CLASS ACTION SUITS
Gadolinium class action suits, as well as individual MRI law suits are being investigated against the makers of these MRI contrasts. The manufacturers failed to research the impact of their product on thos with impaired kidney function and failed to properly warn about the life-altering and potentially fatal side effects of gadolinium MRI contrasts.
The FDA has indicated that all five of the gadolinium MRI contrast agents which are available could cause the serious problems. The majority of all reported cases of involve use of Omniscan (gadodiamide). However, there have been reports of the disorder developing after at least three of the five gadolinium injections.
The gadolinium lawyers at Saiontz, Kirk & Miles, P.A. provide free consultations and claim evaluations to help determine if you, your friend or family member may be entitled to compensation. There are no fees or expenses unless a recovery is obtained.
